These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 168626)

  • 1. Studies on immunisation of pigs with the Bartha strain of Aujeszky's disease virus.
    McFerran JB; Dow C
    Res Vet Sci; 1975 Jul; 19(1):17-22. PubMed ID: 168626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres.
    Van Oirschot JT
    Res Vet Sci; 1987 Jan; 42(1):12-6. PubMed ID: 3029845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on immunity to Aujeszky's disease (pseudorabies) virus infection in pigs.
    McFerran JB
    Dev Biol Stand; 1975; 28():563-70. PubMed ID: 165131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
    Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal vaccination of pigs against Aujeszky's disease: comparison with inactivated vaccines in pigs with low maternal antibody titres.
    De Leeuw PW; Van Oirschot JT
    Res Vet Sci; 1985 Jul; 39(1):34-8. PubMed ID: 2994188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of an intranasal immunization with gEgC and gEgI double-deletion mutants of Aujeszky's disease virus in maternally immune pigs and the effects of a successive intramuscular booster with commercial vaccines.
    Nauwynck HJ; Labarque GG; Pensaert MB
    Zentralbl Veterinarmed B; 1999 Dec; 46(10):713-22. PubMed ID: 10676150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs.
    Arellano PE; Morrison RB; Molitor TW; Thawley DG
    J Am Vet Med Assoc; 1992 Mar; 200(5):685-91. PubMed ID: 1314793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of specific humoral immune response in pigs vaccinated intradermally with deleted Aujeszky's disease vaccine and challenged with virulent strain of Herpesvirus suis type 1.
    Mikulska-Skupień E; Szweda W; Procajło Z
    Pol J Vet Sci; 2005; 8(1):11-6. PubMed ID: 15794468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a pseudorabies virus vaccine based on deletion mutant strain 783 that does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Moormann RJ; Berns AJ; Gielkens AL
    Am J Vet Res; 1991 Jul; 52(7):1056-60. PubMed ID: 1654033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus isolation and immune responses in susceptible swine exposed with pseudorabies virus (Shope strain).
    Pirtle EC; Gutekunst DE
    Am J Vet Res; 1978 Aug; 39(8):1367-8. PubMed ID: 211884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local humoral and cellular responses in Aujeszky's disease virus infection in pigs.
    Martin S; Wardley RC
    Res Vet Sci; 1987 Mar; 42(2):170-4. PubMed ID: 3035662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of memory B-cell responses in serum and mucosal fluids of swine for protective immunity against pseudorabies virus.
    Kimman TG; Oei-Lie N; van Zaane D
    Am J Vet Res; 1992 Nov; 53(11):1992-8. PubMed ID: 1334639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of experimental infection with pseudorabies (Aujeszky's disease) virus on pigs with maternal immunity from vaccinated sows.
    Andries K; Pensaert MB; Vandeputte J
    Am J Vet Res; 1978 Aug; 39(8):1282-5. PubMed ID: 211882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of cattle against pseudorabies (Aujeszky's disease) with homologous virus (herpes suis) and heterologous virus (herpes bovis 1).
    Biront P; Vandeputte J; Pensaert MB; Leunen J
    Am J Vet Res; 1982 May; 43(5):760-3. PubMed ID: 6283963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus.
    van Oirschot JT; Gielkens AL
    Am J Vet Res; 1984 Oct; 45(10):2099-103. PubMed ID: 6093645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal vaccination of pigs against Aujeszky's disease: protective immunity at 2 weeks, 2 months and 4 months after vaccination in pigs with maternal antibodies.
    van Oirschot JT
    Vet Microbiol; 1991 Apr; 27(2):103-13. PubMed ID: 1648282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of fattening pigs against challenge with Aujeszky's disease virus after a successive intranasal/intramuscular vaccination.
    Labarque GG; Nauwynck HJ; Maes DG; Pensaert MB
    Vet Q; 1999 Jun; 21(3):104-7. PubMed ID: 10427636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aujeszky's disease. Studies on the possibility of differentiating between contaminated pig-breeding farms and farms on which the pigs have been inoculated with the Bartha vaccine (author's transl)].
    Van Aarle PA; Truijen WT; Tielen MJ
    Tijdschr Diergeneeskd; 1978 Feb; 103(4):213-9. PubMed ID: 203058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trial of vaccination against Aujeszky's disease].
    Motovski A; Veselinova A; Dobrev V
    Vet Med Nauki; 1980; 17(5):32-7. PubMed ID: 6262995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies of the CFT in the diagnosis of Aujeszky's disease virus in swine].
    Ognianov D; Tamarov G; Panova M
    Vet Med Nauki; 1977; 14(2):26-31. PubMed ID: 199985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.